主席

Opening and Introduction

Association of Body Weight Time in Target Range with the Risk of Major Adverse Cardiovascular Event Outcomes in Patients With Overweight/Obesity, Combined Hypertension, and Type 2 Diabetes Mellitus

Mechanisms of Empagliflozin in Improving Hypertensive Cardiac Remodeling through Sympathetic Nervous System

Interaction between family history of hypertension and dyslipidemia on the risk of hypertension

Digital Profiling of Positive Responders to Antihypertensive Medications: A Step Forward to Personalized Therapy in Hypertension

Nonobese young females with PCOS are at high risk for long-term cardiovascular disease

Childhood Hypertension, Transition to Normotension in Adulthood, and Subclinical Cardiovascular Outcomes in Adults: A 36-Year Prospective Cohort Study

Improved cardiovascular risk prediction using echocardiography in primary prevention for community populations with hypertension

Olaparib reduces the high blood pressure caused by VEGF inhibitors

The association of triglyceride glucose index, triglyceride to high‐density lipoprotein cholesterol ratio and related parameters with prehypertension and hypertension over 45 years old: a cross-sectional study

Knowledge, Attitudes, and Practices (KAP) of Salt Intake among Hypertensives and Normotensives of a Malaysian University Campus

Discussion and Closing